Silverfin false false 31/03/2025 01/04/2024 31/03/2025 Mr K P Patel 21/02/2023 04 November 2025 no description of principal activity 14680531 2025-03-31 14680531 bus:Director1 2025-03-31 14680531 2024-03-31 14680531 core:CurrentFinancialInstruments 2025-03-31 14680531 core:CurrentFinancialInstruments 2024-03-31 14680531 core:ShareCapital 2025-03-31 14680531 core:ShareCapital 2024-03-31 14680531 core:RetainedEarningsAccumulatedLosses 2025-03-31 14680531 core:RetainedEarningsAccumulatedLosses 2024-03-31 14680531 core:ComputerEquipment 2024-03-31 14680531 core:ComputerEquipment 2025-03-31 14680531 2024-04-01 2025-03-31 14680531 bus:FilletedAccounts 2024-04-01 2025-03-31 14680531 bus:SmallEntities 2024-04-01 2025-03-31 14680531 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 14680531 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 14680531 bus:Director1 2024-04-01 2025-03-31 14680531 core:ComputerEquipment core:TopRangeValue 2024-04-01 2025-03-31 14680531 2023-02-21 2024-03-31 14680531 core:ComputerEquipment 2024-04-01 2025-03-31 iso4217:GBP xbrli:pure

Company No: 14680531 (England and Wales)

KP SURGERY LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2025
Pages for filing with the registrar

KP SURGERY LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2025

Contents

KP SURGERY LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 March 2025
KP SURGERY LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 March 2025
Note 31.03.2025 31.03.2024
£ £
Fixed assets
Tangible assets 3 608 0
608 0
Current assets
Debtors 4 6,100 9,677
Cash at bank and in hand 18,835 13,688
24,935 23,365
Creditors: amounts falling due within one year 5 ( 3,306) ( 6,232)
Net current assets 21,629 17,133
Total assets less current liabilities 22,237 17,133
Net assets 22,237 17,133
Capital and reserves
Called-up share capital 1 1
Profit and loss account 22,236 17,132
Total shareholder's funds 22,237 17,133

For the financial year ending 31 March 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of KP Surgery Limited (registered number: 14680531) were approved and authorised for issue by the Director. They were signed on its behalf by:

Mr K P Patel
Director

04 November 2025

KP SURGERY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
KP SURGERY LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial period, unless otherwise stated.

General information and basis of accounting

KP Surgery Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Fir Tree Cottage The Street, Great Barton, Bury St. Edmunds, IP31 2QP, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Computer equipment 5 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

Year ended
31.03.2025
Period from
21.02.2023 to
31.03.2024
Number Number
Monthly average number of persons employed by the Company during the year, including the director 2 2

3. Tangible assets

Computer equipment Total
£ £
Cost
At 01 April 2024 0 0
Additions 674 674
At 31 March 2025 674 674
Accumulated depreciation
At 01 April 2024 0 0
Charge for the financial year 66 66
At 31 March 2025 66 66
Net book value
At 31 March 2025 608 608
At 31 March 2024 0 0

4. Debtors

31.03.2025 31.03.2024
£ £
Trade debtors 2,399 8,245
Amounts owed by director 359 0
Prepayments 3,342 1,432
6,100 9,677

5. Creditors: amounts falling due within one year

31.03.2025 31.03.2024
£ £
Trade creditors 300 198
Amounts owed to director 0 341
Accruals 1,512 1,440
Taxation and social security 1,494 4,253
3,306 6,232